Format

Send to

Choose Destination
See comment in PubMed Commons below
Stem Cells Transl Med. 2012 May;1(5):438-47. doi: 10.5966/sctm.2011-0009. Epub 2012 May 9.

Concise review: cell therapies: the route to widespread adoption.

Author information

1
Newcastle University Business School, Citywall, Citygate, Newcastle Upon Tyne, United Kingdom.

Abstract

We identify three dimensions with which to classify heuristically the routes to widespread adoption of cellular therapies. The first dimension is based on the relative involvement of clinicians and companies in a particular cellular therapy. The second dimension is based on cell type and consequent scale of manufacture. The third dimension classifies the therapeutic intervention as a procedure or product and has perhaps received less attention. We suggest that for those cellular therapies that require therapeutic procedures, close collaboration between companies and clinicians will reduce the time to widespread adoption. For selected cellular therapies we make predictions of the likely time to widespread adoption.

PMID:
23197823
PMCID:
PMC3659704
DOI:
10.5966/sctm.2011-0009
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley Icon for PubMed Central
    Loading ...
    Support Center